Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler boosted Itron, Inc. (NASDAQ:ITRI) price target from $72 to $91. Piper Sandler analyst Kashy Harrison upgraded the stock from Neutral to Overweight. Itron shares rose 0.01% to close at $73.02 on Monday. See how other analysts view this stock.HC Wainwright & Co. cut the price target for Cara Therapeutics, Inc. (NASDAQ:CARA) from $7 to $2.5. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Cara Therapeutics shares fell 48.9%